Reactivation of persistent Epstein–Barr virus (EBV) causes secretion of thyrotropin receptor antibodies (TRAbs) in EBV-infected B lymphocytes with TRAbs on their surface

References

• Kieff, E. D., and A. B. Rickinson. 2006. Epstein–Barr virus and its replication. In Fields Virology, 5th ed. Vol. 2. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2603–2654
   Google Scholar
• Rickinson, A. B., and E. Kieff. 2006. Epstein–Barr virus. In Fields Virology, 5th ed. Vol. 2. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2655–2700
   Google Scholar
• Davies, P., and T. Larsen. 2007. Thyrotoxicosis. In Williams Textbook of Endocrinology, 11th ed. H. M. Kronenberg, S. Melmed, K. S. Polonsky, and P. R. Larsen, eds. Saunders, Philadelphia, PA. p. 333–376
   Google Scholar
• Weetman, A. P., and A. M. McGregor. 1994. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15: 788–830
   PubMed Web of Science ®Google Scholar
• Tomer, Y., and A. Huber. 2009. The etiology of autoimmune thyroid disease: a story of genes and environment. J. Autoimmun. 32: 231–239
   PubMed Web of Science ®Google Scholar
• Tomer, Y., A. Greenberg, G. Barbesino, et al. 2001. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. JCEM. 86: 1687–1693
   PubMed Web of Science ®Google Scholar
• Ueda, H., J. M. M. Howson, L. Esposito, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506–511
   PubMed Web of Science ®Google Scholar
• Nagata, K., S. Fukata, K. Kanai, et al. 2011. The influence of Epstein–Barr virus reactivation in patients with Graves' disease. Viral Immunol. 24: 143–149
   PubMed Web of Science ®Google Scholar
• Nagata, K., K. Higaki, Y. Nakayama, et al. 2014. Presence of Epstein–Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individuals. Autoimmunity 47: 193–200
   PubMed Web of Science ®Google Scholar
• Crawford, D. H., and I. Ando. 1986. EB virus induction is associated with B-cell maturation. Immunology 59: 405–409
   PubMed Web of Science ®Google Scholar
• Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein–Barr virus in vivo. J. Virol. 79: 1296–1307
   PubMed Web of Science ®Google Scholar
• Frisan, T., V. Levitsky, and M. Masucci. 2001. Generation of lymphoblastoid cell lone (LCLs). In Epstein–Barr Virus Protocols (Method in Molecular Biology), Vol. 174. J. Wilson, and G. H. W. May, eds. Humana Press, Totowa, NJ. p. 125–127
   Google Scholar
• Hinuma, Y., M. Konn, J. Yamaguchi, et al. 1967. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1: 1045–1051
   PubMedGoogle Scholar
• Sairenji, T., and Y. Hinuma. 1980. Re-evaluation of a transforming strain of Epstein–Barr virus from the Burkitt lymphoma cell line, Jijoye. Int. J. Cancer 26: 337–342
   PubMed Web of Science ®Google Scholar
• Sairenji, T., G. Bertoni, M. M. Medveczky, et al. 1988. Inhibition of Epstein–Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. J. Virol. 62: 2614–2421
   PubMed Web of Science ®Google Scholar
• Kimura, H., K. Miyake, Y. Yamauchi, et al. 2009. Identification of Epstein–Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative disease. J. Infect. Dis. 200: 1073–1087
   Web of Science ®Google Scholar
• Hoffman, G. J., S. G. Lazarowits, and S. D. Hayward. 1980. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein–Barr virus identifies a membrane antigen and a neutralizing antigen. Proc. Natl. Acad. Sci. USA 77: 2979–2983
   PubMed Web of Science ®Google Scholar
• Pellett, P. E., and B. Roizman. 2006. The family Herpesviridae: a brief introduction. In Fields Virology, 5th ed. Vol. 2. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, PA. p. 2479–2499
   Google Scholar
• Liu, J., J. D. FarmerJr, W. S. Lane, et al. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807–815
   PubMed Web of Science ®Google Scholar
• Clipstone, N. A., and G. R. Crabtree. 1992. Identification of calcineurin as a key signaling enzyme in T-lymphocyte activation. Nature 357: 695–697
   PubMed Web of Science ®Google Scholar
• Chen, C., T. D. Johnston, H. Jeon, et al. 2009. Cyclosporine promotes Epstein–Barr virus-infected human B-cell transformation assayed by three correlated assay methods. Transplant. Proc. 41: 366–370
   PubMed Web of Science ®Google Scholar
• Bryant, H., and P. J. Farrell. 2002. Signal transduction and transcription factor modification during reactivation of Epstein–Barr virus from latency. J. Virol. 76: 10290–10298
   PubMed Web of Science ®Google Scholar